lung
epitheli
surfac
one
vital
barrier
sensor
bodi
respond
extern
atmospher
therebi
alway
subject
direct
toxicolog
exposur
stress
stimulu
infect
due
rel
higher
sensit
respons
toxic
use
lung
epitheli
cell
cultur
lung
tissu
anim
model
patient
facilit
learn
lung
physiopatholog
toxicopharmacolog
recent
advanc
proteom
made
possibl
investig
cellular
respons
global
level
review
potenti
applic
proteom
approach
studi
lungrel
diseas
biomark
discoveri
discuss
lung
vital
organ
respir
anatom
point
view
lung
exhibit
special
architectur
quit
resembl
organ
bodi
reflect
design
role
gaseou
exchang
weibel
gomez
substanc
lung
light
spongi
textur
gener
lung
around
million
alveoli
individu
alveolu
wrap
bundl
capillari
primari
site
gaseou
exchang
blood
take
place
weibel
gomez
alveoli
consist
epitheli
layer
extracellular
matrix
surround
capillari
three
main
alveolar
cell
type
alveolar
wall
name
type
cell
type
ii
cell
macrophag
type
cell
cell
made
alveolar
wall
wherea
type
ii
cell
secretori
cell
secret
surfact
form
aqueou
proteincontain
layer
facilit
gaseou
exchang
well
prevent
collaps
alveoli
penney
needless
say
macrophag
critic
mediat
cellular
defens
foreign
invad
like
germ
virus
bowden
note
lung
epitheli
surfac
one
vital
barrier
sensor
bodi
respond
extern
atmospher
therebi
alway
subject
direct
toxicolog
exposur
stress
stimulu
infect
result
respiratori
system
inevit
ideal
locat
prone
variou
diseas
complic
tabl
world
health
organ
past
decad
use
lung
epitheli
cell
cultur
lung
tissu
anim
model
patient
facilit
learn
lung
physiopatholog
toxicopharmacolog
even
without
assist
comprehens
tool
understand
field
would
hamper
light
util
proteom
approach
becom
indispens
tool
proven
use
elucid
mechan
well
find
cure
variou
emerg
lung
diseas
vast
emerg
literatur
publish
year
review
potenti
applic
proteom
approach
studi
lungrel
diseas
biomark
discoveri
discuss
gener
three
major
type
studi
sampl
employ
lung
cell
proteom
studi
includ
vitro
lung
cell
cultur
bronchial
fluid
obtain
lung
bronchoalveolar
lavag
fluid
balf
wattiez
falmagn
sputum
secret
expector
respiratori
tract
kip
et
al
well
bodi
fluid
ie
serum
plasma
blood
cell
urin
instanc
tradit
method
use
lung
tissu
biopsi
autopsi
fig
overal
method
merit
understand
etiolog
diseas
action
mechan
agent
lung
cell
usual
biomark
studi
sampl
bodi
fluid
conveni
way
obtain
start
materi
compar
use
biopsi
autopsi
gener
geneknockout
mice
eg
cystic
fibrosi
cf
transmembran
receptor
knockout
mice
studi
model
cf
also
tremend
facilit
discoveri
biomark
understand
sever
genet
diseas
bensalem
et
al
brouillard
et
al
order
facilit
process
biomark
discoveri
mani
enrich
method
strategi
develop
recent
year
advanc
proteom
push
level
investig
proteom
individu
organel
socal
subcellular
proteom
scenario
particular
type
organel
insid
cell
exampl
mitochondria
nuclear
first
separ
cellular
compon
studi
lau
et
al
wang
et
al
method
reduc
complex
also
indirectli
provid
enrich
protein
studi
corollari
facilit
resolut
protein
separ
enhanc
sensit
protein
detect
mass
spectrometri
subcellular
proteom
particularli
use
delin
function
signific
subcellular
local
protein
convent
proteom
use
whole
cell
extract
never
achiev
result
use
laser
captur
dissect
tissu
effici
obtain
homogen
cell
type
research
instead
contamin
mixtur
cancer
normal
cell
gutstein
morri
method
like
albumin
deplet
serum
sampl
proteom
analysi
also
facilit
identif
biomark
otherwis
mask
albumin
protein
gel
lei
et
al
addit
partial
purif
concentr
substanc
secret
lung
fluid
releas
cultur
medium
cultur
lung
cell
challeng
stimulatori
agent
also
greatli
provid
good
mean
proteom
studi
lung
respons
identifi
biomark
variou
diseas
complic
use
variou
cuttingedg
proteom
approach
recent
year
lot
newli
identifi
biomark
lungrel
diseas
report
articl
particularli
interest
studi
genet
diseas
inflammatori
allergi
diseas
infecti
diseas
lung
cancer
cf
autosom
recess
inherit
diseas
result
mutat
cystic
fibrosi
transmembran
conduct
receptor
cftr
gene
tsui
zielenski
tsui
mutat
receptor
result
defect
anion
secret
excess
na
reuptak
across
epithelia
lead
insuffici
intralumin
hydrat
caus
mucu
accumul
defect
impact
state
intestin
well
impair
mucociliari
clearanc
airway
stutt
et
al
kunzelmann
mall
current
cure
individu
cf
howev
indepth
studi
would
allow
scientist
understand
mechan
govern
etiolog
diseas
effect
medic
could
appli
patient
prolong
lifespan
result
diseas
sever
recent
proteom
studi
provid
interest
candid
protein
possibl
biomark
cf
shown
low
abund
inflammatoryassoci
autoantigen
like
myeloperoxidas
identifi
immunoproteom
approach
sputum
subject
cf
approach
also
exploit
detect
protein
express
pseudomona
aeruginosa
strain
frequent
pathogen
organ
invad
lung
cf
patient
captur
antigen
use
circul
antibodi
cf
subject
implic
vivo
express
pseudomona
protein
cf
subject
test
control
immunoreact
immunocaptur
pseudomona
protein
implic
possibl
biomark
p
aeruginosa
infect
anoth
studi
salineinduc
sputum
adult
cf
exacerb
extens
proteolyt
igg
degrad
influx
inflammationrel
protein
observ
indic
chang
predictor
cf
lung
exacerb
also
main
highmolecular
mass
protein
sputum
subject
mucin
appear
degrad
cf
adult
journal
cellular
physiolog
exacerb
glycosyl
mucin
also
show
reduc
sulfat
increas
sialyl
reduc
fucosyl
cf
adult
compar
control
schulz
et
al
besid
use
sputum
serum
sampl
cf
patient
pool
compar
equival
pool
control
sera
order
identifi
pattern
protein
express
uniqu
cf
antibodi
microarray
set
significantli
differenti
express
protein
enrich
protein
mediat
inflamm
nfkb
signal
pathway
also
pediatr
cf
patient
selditofm
balf
profil
identifi
uniqu
reliabl
protein
includ
neutrophil
protein
adefensin
calciumbind
protein
well
novel
form
equival
ctermin
delet
concentr
molecul
abnorm
high
earli
cf
patient
data
provid
new
insight
cf
lung
diseas
identifi
novel
protein
strongli
associ
cf
airway
inflamm
mcmorran
et
al
use
cf
bronchial
biopsi
normal
cf
patient
chaperon
kda
glucoseregul
protein
ubiquinolcytochrom
c
reductas
complex
core
protein
one
form
nidogen
pseudogen
aconitas
increas
cf
aberr
chaperon
metabol
protein
cf
may
reflect
molecular
chang
cf
well
cflink
inflamm
infect
cellular
stress
respons
frischer
et
al
examin
protein
profil
cultur
cf
lung
epitheli
cell
analysi
gave
rise
identifi
protein
among
high
abund
protein
identifi
set
protein
associ
inflamm
includ
classic
nfkb
rela
nfkb
relb
pollard
et
al
follow
studi
compar
cell
daughter
cell
repair
gene
transfer
aav
wildtyp
cftr
simultan
measur
de
novo
biosynthet
rate
methionin
protein
cell
type
result
identif
addit
cfspecif
protein
kinet
portion
high
abund
cf
proteom
hidden
direct
analysi
abund
includ
protein
transcript
signal
pathway
nfkb
chaperon
cytoskelet
protein
other
conclus
studi
measur
biosynthet
rate
global
scale
could
use
identifi
diseasespecif
differ
within
high
abund
cf
proteom
final
use
cftr
mice
annexin
found
absent
colon
crypt
concurr
annexin
also
undetect
lung
pancrea
mice
suggest
absenc
inhibitori
mediat
host
inflammatori
respons
associ
colon
upregul
proinflammatori
cytosol
phospholipas
importantli
annexin
also
downregul
nasal
epitheli
cell
cf
patient
suggest
decreas
express
annexin
contribut
worsen
cf
phenotyp
bensalem
et
al
follow
studi
group
also
demonstr
member
famili
calciumactiv
chlorid
channel
consid
key
molecul
mucu
secret
globlet
cell
significantli
decreas
colon
lung
cftr
mice
result
substanti
conclus
cicarel
function
cf
colon
depend
cftr
express
may
correl
impair
express
brouillard
et
al
asthma
chronic
disord
airway
inflamm
character
variabl
airflow
obstruct
bronchial
hyperrespons
maddox
schwartz
suggest
thelper
type
lymphocyt
cytokin
produc
conjunct
reactiv
oxygen
speci
ro
reactiv
nitrogen
speci
rn
produc
inflammatori
epitheli
cell
contribut
key
mediat
chronic
airway
inflamm
asthma
calhoun
et
al
horwitz
buss
renauld
zhou
et
al
airway
surfac
cover
thin
fluid
layer
term
airway
surfac
liquid
act
barrier
protect
underli
epithelium
widdicomb
identif
secret
protein
fluid
may
import
understand
etiolog
asthma
use
ovalbumin
ova
allergen
mous
model
asthma
sever
group
research
provid
new
insight
pathogenesi
asthma
may
use
surrog
biomark
asthma
shown
ovainduc
oxid
stress
result
proteolysi
consequ
upregul
cytosol
phospholipas
activ
leukotrien
product
lung
mice
chung
et
al
nitrotyrosin
marker
cellular
oxid
stress
differ
protein
target
nitrat
follow
ova
challeng
includ
antioxid
enzym
catalas
oxid
modif
cy
catalas
loss
enzym
activ
observ
subsequ
analysi
human
balf
show
catalas
activ
reduc
asthma
compar
normal
control
studi
provid
insight
catalas
inactiv
might
one
culprit
contribut
chronic
inflammatori
state
asthmat
airway
ghosh
et
al
studi
show
lungkin
recent
describ
chemokin
famili
chitinas
includ
acid
mammalian
chitinas
protein
mediat
mucu
secret
surfact
proteind
ctype
lectin
capabl
modul
inflammatori
respons
significantli
increas
balf
ovatr
asthmat
mice
zhao
et
al
zhang
et
al
final
use
plasma
peptid
control
chronic
asthma
mice
induc
ova
author
quantit
identifi
fragment
f
complement
import
inflamm
significantli
higher
control
chronic
asthma
mice
studi
suggest
nativ
small
peptid
detect
techniqu
may
use
specif
biomark
diseas
yeo
et
al
human
subject
clinic
studi
patient
use
peripher
tlymphocyt
six
normal
individu
six
patient
asthma
increas
express
phosphodiesteras
decreas
express
glutathion
stransferas
confirm
asthmat
patient
may
indic
import
biomark
therapeut
target
jeong
et
al
final
shown
gelsolin
level
elev
balf
patient
asthma
elev
level
gelsolin
propos
improv
fluiditi
airway
surfac
liquid
asthma
break
filament
actin
releas
die
cell
inflamm
candiano
et
al
acut
respiratori
distress
syndrom
ard
import
caus
morbid
mortal
critic
ill
patient
ware
matthay
character
acut
pulmonari
inflammatori
process
epitheli
apoptosi
interstiti
intraalveolar
edema
subsequ
fibroblast
prolifer
migrat
fibrosi
dechert
use
shotgun
proteom
sever
interest
protein
identifi
balf
patient
ard
includ
insulinlik
growth
factorbind
normal
control
low
level
wherea
patient
earli
ard
signific
increas
result
exhibit
igf
pathway
regul
apoptosi
lung
fibroblast
lung
epitheli
cell
igf
pathway
may
contribut
fibroprolif
respons
ard
schnapp
et
al
anoth
studi
use
selditof
electrophoresisbas
proteom
found
increas
level
apolipoprotein
protein
balf
subject
challeng
bronchial
lung
endotoxin
patient
ard
de
torr
et
al
addit
recent
studi
order
address
complex
dynam
chang
occur
cours
ard
quantit
proteom
approach
employ
profil
protein
balf
patient
ard
day
onset
ill
compar
healthi
control
subject
result
indic
enrich
protein
involv
inflamm
infect
injuri
ard
patient
protein
network
analysi
signifi
protein
interact
ard
complex
redund
reveal
unexpect
central
compon
protein
network
nevertheless
data
studi
demonstr
new
relationship
among
protein
identifi
new
group
mediat
could
target
novel
treatment
chang
et
al
chronic
obstruct
pulmonari
diseas
copd
lung
diseas
airway
becom
narrow
lead
limit
airflow
caus
short
breath
barn
et
al
contrast
asthma
limit
airflow
poorli
revers
syndrom
worsen
progress
time
cigarett
smoke
expos
lung
high
concentr
ro
major
risk
factor
copd
hogg
one
goal
copd
research
identif
biomark
earli
diagnosi
diseas
increas
level
surfact
proteina
spa
found
copd
normal
fibrot
lung
also
elev
spa
protein
level
detect
induc
sputum
supernat
copd
patient
level
surfact
protein
spb
spc
spd
alter
data
reveal
spa
link
pathogenesi
copd
could
consid
potenti
copd
biomark
ohlmeier
et
al
recent
studi
serum
amyloid
saa
identifi
novel
blood
biomark
acut
exacerb
copd
aecopd
sensit
creactiv
protein
alon
combin
dyspnea
saa
may
offer
new
insight
pathogenesi
aecopd
bozinovski
et
al
combin
seldiand
malditofm
analysi
result
signifi
concentr
neutrophil
defensin
elev
balf
smoker
copd
compar
asymptomat
smoker
increas
concentr
salivari
prolinerich
peptid
pc
lysozym
c
detect
balf
asymptomat
smoker
compar
nonsmok
wherea
salivari
prolinerich
pd
clara
cell
phospholipidsbind
protein
reduc
concentr
identifi
protein
peptid
might
use
futur
diagnost
marker
smokeinduc
lung
irrit
copd
merkel
et
al
sever
unfold
protein
respons
upr
protein
shown
upregul
chronic
smoker
compar
nonsmok
exsmok
includ
chaperon
glucoseregul
protein
calreticulin
foldas
protein
disulfid
isomeras
pdi
enzym
involv
antioxid
defens
clinic
relev
studi
chronic
smoke
induc
endoplasm
reticulum
stress
respons
human
lung
failur
compensatori
system
may
contribut
develop
copd
kelsen
et
al
lastli
lung
tissu
obtain
nonsmok
smoker
without
copd
smoker
copd
found
thioredoxinlik
increas
patient
copd
two
protein
increas
healthi
smoker
group
increas
copd
group
suggest
might
close
associ
develop
airflow
limit
lee
et
al
particul
also
known
ambient
particul
matter
pm
tini
airborn
particl
correl
inhal
pm
increas
morbid
mortal
respiratori
diseas
laden
et
al
samet
et
al
shown
dose
rang
mgml
organ
diesel
exhaust
particl
dep
extract
induc
progress
oxid
stress
macrophag
cell
line
malditofm
analysi
show
newli
induc
nacsuppress
protein
identifi
includ
antioxid
enzym
heme
catalas
proinflammatori
compon
mapk
rel
product
intermediari
metabol
regul
oxid
stress
xiao
et
al
later
group
research
show
treatment
cell
organ
dep
chemic
caus
induct
least
protein
among
heat
shock
protein
tcomplex
protein
zetasubunit
known
play
role
upr
dep
extract
also
induc
express
cultur
supernat
respons
could
abrog
presenc
nac
data
exhibit
dep
induc
oxid
stress
respons
upr
proinflammatori
effect
protein
may
serv
marker
pm
exposur
airborn
pm
aerodynam
diamet
less
mm
complex
mixtur
organ
inorgan
compound
contain
sulfat
variou
metal
titanium
pagan
et
al
acut
chronic
exposur
tio
particl
shown
induc
inflammatori
respons
airway
alveolar
space
rat
schapira
et
al
warheit
et
al
ahn
et
al
kang
et
al
tio
treat
rat
test
good
model
studi
human
epitheli
respons
particl
treatment
epitheli
cell
bsacoat
tio
particl
alter
express
protein
includ
defenserel
cell
activ
cytoskelet
protein
implic
respons
oxid
stress
among
one
protein
macrophag
migrationinhibitori
factor
mif
mif
express
primarili
epithelium
elev
lung
tissu
balf
tio
treat
rat
interestingli
carbon
black
dep
also
induc
express
mif
protein
epitheli
cell
cha
et
al
last
least
ultrafin
carbon
black
ufcb
carboncent
ultrafin
particl
mm
diamet
compris
major
fine
particul
matter
rster
utel
significantli
greater
increas
neutrophil
influx
total
protein
balf
observ
intratrach
instil
ufcb
compar
carbon
black
nm
diamet
li
et
al
ufcb
also
act
rosdepend
pathway
caus
vascular
endotheli
growth
factor
vegf
product
lung
injuri
mice
chang
et
al
proteom
studi
carri
balf
mice
treatment
ufcb
result
show
ufcb
exposur
caus
increas
epiderm
growth
factor
receptor
egfr
leukemia
inhibitori
factor
receptor
lifr
balf
decreas
receptor
lung
tissu
suggest
acceler
epitheli
shed
lung
increas
cell
debri
membran
protein
egfr
lifr
balf
data
reveal
mechan
involv
pathogenesi
ufcbinduc
lung
injuri
chang
et
al
sever
acut
respiratori
syndrom
sar
caus
coronaviru
cov
also
known
atyp
pneumonia
emerg
pandem
threat
drosten
et
al
ksiazek
et
al
peiri
et
al
understand
pathogenesi
develop
specif
diagnost
method
earli
diagnosi
crucial
effect
manag
control
diseas
although
genom
sequenc
compar
analysi
provid
abund
inform
predict
structur
function
protein
compris
viru
possibl
posttransl
modif
cleavag
product
difficult
obtain
genom
sequenc
use
sarscovinfect
vero
cell
sever
studi
provid
new
perspect
function
sarscov
viral
protein
cellular
respons
group
identifi
character
structur
protein
sarscov
isol
vero
cell
infect
strain
viru
ying
et
al
anoth
studi
cytosol
nucleu
fraction
sarscovinfect
cell
well
crude
virion
analyz
onedimension
electrophoresi
follow
esimsm
identif
shotgun
strategi
twodimension
liquid
chromatographyesimsm
four
predict
structur
protein
sarscov
includ
spike
membran
n
nucleocapsid
e
envelop
protein
identifi
studi
indic
ms
made
contribut
rapidli
accur
character
whether
cell
contain
viru
may
use
rapid
screen
viru
virusinfect
cell
even
bodi
fluid
zeng
et
al
character
protein
sarscov
infect
vero
cell
sera
sar
patient
show
tendenc
exist
comut
protein
spike
protein
sarscov
isol
conclus
protein
might
tightli
correl
spike
protein
sarscov
function
may
serv
new
clinic
marker
drug
target
sar
treatment
zeng
et
al
analyz
differenti
cellular
respons
sarscov
proteom
vero
cell
without
infect
sarscov
resolv
quantit
twodimension
gel
electrophoresi
follow
esimsm
identif
also
icat
technolog
coupl
twodimension
lcmsm
appli
differenti
protein
infect
cell
combin
two
method
uniqu
protein
identifi
quantit
differenti
express
perhap
far
comprehens
proteom
index
sarscovinfect
cell
identifi
differenti
profil
furnish
valuabl
resourc
diagnosi
drug
develop
treatment
sar
jiang
et
al
use
serum
sar
patient
sever
group
includ
provid
use
biomark
diagnosi
sar
studi
use
proteom
technolog
show
truncat
form
antitrypsin
tfa
increas
significantli
consist
sera
sar
patient
compar
control
subject
dramat
increas
tfa
may
result
degrad
play
import
role
protect
lung
function
degrad
may
import
factor
pathogenesi
sar
also
may
use
biomark
diagnosi
sar
ren
et
al
use
selditofm
analysi
sera
collect
sar
patient
sera
control
patient
variou
viral
bacteri
infect
sera
appar
healthi
individu
significantli
increas
significantli
decreas
serum
biomark
discov
sar
patient
compar
control
among
upregul
marker
saa
protein
confirm
tandem
mass
spectrometr
analysi
good
correl
saa
concentr
extent
pneumonia
saa
could
use
monitor
diseas
activ
respons
treatment
sar
patient
yip
et
al
anoth
studi
use
serum
patient
earlystag
sar
infect
suspect
sar
patient
sar
outbreak
period
author
report
proteom
featur
highest
diagnost
valu
ntermin
fragment
complement
achain
intern
fragment
fibrinogen
ae
chain
pang
et
al
recent
studi
coronaviru
proteom
microarray
contain
entir
proteom
human
sarscov
five
addit
coronavirus
construct
microarray
use
screen
canadian
sera
sar
outbreak
includ
sampl
confirm
sarscov
case
respiratori
ill
patient
healthcar
profession
array
serv
rapid
sensit
simpl
tool
largescal
identif
viralspecif
antibodi
sera
besid
serum
proteom
plasma
sar
patient
investig
complet
proteom
analysi
perform
four
patient
sar
differ
time
cours
total
differenti
spot
select
protein
identif
protein
identifi
acut
phase
protein
presenc
repres
consequ
serial
cascad
initi
sarscov
infect
sever
protein
never
identifi
plasma
use
gel
electrophoresi
among
peroxiredoxin
ii
prx
ii
high
level
plasma
prx
ii
patient
sar
could
secret
cell
indic
activ
innat
immun
respons
along
oxidationassoci
injuri
may
play
role
pathogenesi
sar
anoth
recent
studi
plasma
protein
sar
patient
normal
control
group
compar
enrich
lowabund
protein
human
plasma
two
highli
abund
protein
albumin
igg
first
deplet
upregul
protein
identifi
acid
glycoprotein
haptoglobin
antichymotrypsin
fetuin
downregul
protein
apolipoprotein
transferrin
transthyretin
sinc
upregul
protein
identifi
wellknown
inflamm
inhibitor
mechan
sustain
inflamm
balanc
sar
patient
help
proper
treatment
therapi
diseas
wan
et
al
approxim
one
third
world
popul
current
infect
pathogen
nearli
million
peopl
die
tb
annual
clarkcurtiss
haydel
tuberculosi
facult
intracellular
bacterium
persist
replic
within
host
phagocyt
predominantli
macrophag
dendrit
cell
clarkcurtiss
haydel
upon
phagocytosi
tuberculosi
establish
earli
endosom
compart
arrest
phagosom
matur
replic
colon
persist
colon
phagosom
host
phagocyt
develop
drug
resist
make
tb
one
top
diseas
caus
peopl
die
diseas
world
world
health
organ
therefor
proteom
technolog
becom
indispens
tool
identifi
earli
diagnost
marker
tb
identifi
protein
tuberculosi
uniqu
intraphagosom
phase
mycobacteria
purifi
phagosom
infect
murin
bone
marrowderiv
macrophag
analyz
ms
result
indic
mycobacteri
protein
exclus
detect
intraphagosom
mycobacteria
compar
brothcultur
mycobacteria
six
identifi
protein
observ
phagosom
mycobacteria
name
phosphoglycer
mutas
gpm
lipid
carrier
protein
put
potassium
uptak
protein
trka
conserv
hypothet
protein
identifi
previous
brothcultur
mycobacteria
suggest
protein
inde
uniqu
phagosom
tuberculosi
identif
role
protein
target
drug
design
would
allow
direct
interfer
function
control
intracellular
growth
mycobacteria
mattow
et
al
anoth
studi
protein
secret
cultur
medium
tuberculosi
kstrain
preval
among
clinic
isol
korea
belong
beij
famili
analyz
page
compar
tuberculosi
strain
eleven
protein
identifi
malditofm
lcesim
protein
clone
express
e
coli
affin
purifi
use
three
recombin
protein
enzymelink
immunosorb
assay
elisa
sera
tb
patient
sera
healthi
control
analyz
show
sensit
specif
respect
result
display
protein
express
abundantli
recent
obtain
clinic
isol
tuberculosi
laboratoryadapt
strain
promis
use
serodiagnosi
tb
bahk
et
al
put
glyoxalas
cultur
filtrat
grow
tuberculosi
origin
annot
design
identifi
clone
character
express
provid
serum
recognit
recombin
tb
patient
elisa
well
direct
detect
elisa
induc
sputum
sampl
pulmonari
tb
patient
interestingli
per
sampl
sputum
level
potenti
indic
increas
bacteri
burden
correl
level
express
sputum
immunosuppress
cytokin
put
contribut
factor
diseas
progress
level
gamma
interferon
key
cytokin
protect
immun
respons
tb
measur
elisa
togeth
data
suggest
may
use
diagnost
drug
andor
vaccin
target
tb
huard
et
al
novel
serolog
marker
tb
identifi
serolog
proteom
analysi
promis
antigen
serodiagnosi
tb
suggest
combin
previous
identifi
antigen
conjunct
novel
tuberculosi
antigen
would
lead
optim
sensit
serodiagnosi
tb
potenti
improv
clinic
sensit
tbposit
individu
coinfect
hiv
hendrickson
et
al
follow
studi
group
report
use
multiepitop
polyprotein
serodiagnosi
activ
tb
time
three
tb
antigen
also
known
test
togeth
previous
report
protein
well
previous
identifi
antigen
improv
reactiv
observ
indic
use
multipl
antigen
singl
polyprotein
use
facilit
develop
highli
sensit
test
tuberculosi
antibodi
detect
houghton
et
al
final
recent
studi
serum
proteom
profil
obtain
patient
activ
tb
control
selditofm
supervis
machinelearn
approach
base
support
vector
machin
svm
use
obtain
classifi
distinguish
group
two
independ
test
set
classifi
train
inform
peak
achiev
diagnost
accuraci
two
peptid
saa
protein
transthyretin
identifi
quantit
immunoassay
sinc
peptid
reflect
inflammatori
state
author
also
quantit
neopterin
creactiv
protein
applic
svm
classifi
use
combin
valu
gave
diagnost
accuraci
tb
potenti
biomark
tb
identifi
studi
proteom
fingerprint
pattern
recognit
plausibl
biolog
connect
diseas
could
use
develop
new
diagnost
test
agranoff
et
al
lung
cancer
malign
diseas
heterogen
histolog
divid
two
major
group
small
cell
lung
cancer
sclc
nonsmal
cell
lung
cancer
nsclc
nsclc
account
lung
cancer
fall
three
major
type
squamou
cell
carcinoma
scc
adenocarcinoma
larg
cell
lung
cancer
lclc
also
less
frequent
found
carinoid
srivastava
et
al
cigarett
smoke
lead
caus
lung
cancer
result
death
toll
million
annual
ezzati
et
al
worldwid
mortal
rate
increas
probabl
due
earli
smoke
trend
teenag
group
cigarett
made
tobacco
contain
thousand
known
unknown
toxic
compound
carcinogen
strongli
promot
lung
cancer
develop
lung
cancer
may
seen
chest
xray
comput
tomographi
ct
scan
swensen
et
al
diagnosi
confirm
biopsi
possibl
treatment
includ
surgeri
chemotherapi
radiotherapi
treatment
administr
patient
surviv
rate
around
jemal
et
al
although
earli
treatment
seem
promis
higher
surviv
rate
virtual
imposs
cure
advanc
stage
lung
cancer
matter
urgent
need
set
biomark
earli
lung
cancer
detect
well
proper
drug
develop
treat
diseas
beer
group
seri
lung
adenocarcinoma
uninvolv
lung
sampl
examin
result
indic
antioxid
enzym
atp
synthas
subunit
cytosol
inoragan
pyrophosphatas
glucoseregul
mr
protein
glutathionestransferas
prolyl
b
subunit
triosephosph
isomeras
ubiquitin
thiolesteras
identifi
significantli
overexpress
lung
adenocarcinoma
use
batch
sampl
beer
group
also
demonstr
isoform
cytokeratin
occur
significantli
higher
level
tumor
compar
uninvolv
adjac
tissu
similarli
recent
studi
also
demonstr
increas
express
cadmiuminduc
lung
cell
transform
lau
chiu
suggest
increas
express
specif
cytokeratin
act
scaffold
bind
apoptot
factor
prevent
function
provid
addit
surviv
advantag
evad
apoptosi
therefor
specif
isoform
individu
ck
may
util
diagnost
predict
marker
lung
tumorigenesi
use
laser
captur
microdissect
differenti
protein
primari
lung
adenocarcinoma
lnm
adc
without
lymph
node
metastasi
nonlnm
adc
identifi
found
annexin
significantli
upregul
lnm
adc
compar
nonlnm
adc
immunohistochemistri
also
show
annexin
overexpress
frequent
observ
lnm
adc
match
lymph
node
metastas
compar
nonlnm
adc
data
indic
annexin
might
serv
novel
biomark
lymph
node
metastasi
prognosi
lung
adenocarcinoma
liu
et
al
compar
proteom
analysi
human
lung
squamou
carcinoma
hlsc
tissu
pair
normal
bronchial
epitheli
tissu
reveal
differenti
protein
among
protein
identifi
pmf
serolog
proteom
analysi
hlsc
tissu
perform
identifi
tumorassoci
antigen
result
reveal
ae
differenti
protein
reactiv
patient
autolog
sera
protein
identifi
six
protein
alpha
enolas
preb
cellenhanc
factor
precursor
triosephosph
isomeras
phosphoglycer
mutas
fructosebisphosph
aldolas
guanin
nucleotidebind
protein
beta
subunitlik
protein
upregul
hlsc
indic
potenti
applic
hlscassoci
antigen
diagnosi
therapi
hlsc
anoth
studi
author
investig
distribut
express
variou
prx
isoform
lung
cancer
compar
normal
lung
human
mous
among
prx
isoform
immunohistochem
stain
show
isoform
prx
ii
iii
v
predominantli
express
bronchial
alveolar
epithelium
well
alveolar
macrophag
normal
mous
lung
isoform
iii
overexpress
lung
cancer
tissu
compar
normal
lung
upregul
prx
prx
iii
lung
cancer
tissu
may
advantag
tumor
cell
surviv
oxid
stress
microenviron
park
et
al
use
tobacco
carcinogen
nicotinederiv
nitrosamin
nmethylnnitrosamino
nnk
hamster
pulmonari
adenocarinoma
pac
model
human
pac
tissu
array
match
unmatch
normal
lung
tissu
shown
effector
egfr
phosphoryl
creb
effector
badrenoreceptor
overexpress
signific
subset
human
pac
could
serv
earli
biomark
pac
develop
cekanova
et
al
proteom
analysi
urin
sampl
healthi
donor
lung
cancer
patient
nsclc
adenocarcinoma
cell
type
interest
biomark
glycoprotein
transthyretin
g
activ
protein
igfre
light
chain
found
differenti
express
tantipaiboonwong
et
al
use
panel
serum
biomark
diagnosi
lung
cancer
found
carcinoembryon
antigen
retinol
bind
protein
antitrypsin
scc
antigen
collect
found
correctli
classifi
major
lung
cancer
control
patient
patz
et
al
besid
biopsi
sever
proteom
studi
variou
lung
cancer
cell
line
perform
compar
express
proteom
analysi
human
normal
malign
lung
epitheli
cell
found
aldehyd
dehydrogenas
prx
fatti
acid
bind
protein
aldoketoreductas
destrin
upregul
wherea
transgelin
stathmin
downregul
augment
express
prx
confirm
cancer
tissu
compar
normal
tissu
lung
cancer
patient
suggest
could
potenti
biomark
lung
cancer
chang
et
al
mbe
human
bronchial
epitheli
cell
line
phenotyp
featur
earli
tumorigenesi
high
passag
cultur
condit
media
collect
secretori
protein
cathepsin
found
increas
either
cultur
media
cell
passag
tissu
microarray
sandwich
elisa
analys
also
valid
significantli
higher
level
cathepsin
scc
tissu
well
plasma
lung
squamou
cell
carcinoma
patient
respect
compar
normal
donor
indic
potenti
role
biomark
lung
cancer
lou
et
al
similarli
use
nsclc
cell
line
protein
found
secret
condit
medium
includ
peptidylprolyl
cistran
isomeras
manganes
superoxid
dismutas
prx
phosphatidylethanolaminebind
protein
glutathion
stransferas
p
ubiquitin
carboxyltermin
hydrolas
isozym
alpha
enolas
phosphoglycer
mutas
dihydrodiol
dehydrogenas
ddh
compar
normal
lung
tissu
higher
ddh
mrna
protein
express
level
found
nsclc
tissu
concurr
serum
level
ddh
significantli
higher
nsclc
patient
nonmalign
lung
tumor
healthi
control
data
suggest
ddh
could
serv
tissu
marker
novel
serolog
marker
nsclc
protein
profil
four
differ
human
nsclc
cell
line
compar
normal
human
bronchial
epitheli
cell
use
malditofm
among
protein
identifi
tumor
suppressor
gene
downregul
wherea
protooncogen
translat
elong
factor
upregul
nsclc
cell
line
protein
may
share
among
nsclc
cell
line
close
tie
lung
carcinogenesi
final
determin
metastasisassoci
protein
nsclc
compar
proteom
analysi
perform
two
nsclc
cell
line
differ
metastat
potenti
nonmetastat
highli
metastat
cell
line
result
indic
upregul
express
nsclc
tissu
significantli
associ
higher
tumornodemetastasi
stage
posit
lymph
node
statu
indic
might
import
regulatori
molecul
promot
invas
metastasi
nsclc
tian
et
al
review
summar
panel
biomark
among
commonli
contract
lungrel
diseas
world
forecast
emerg
stateoftheart
cuttingedg
technolog
proteom
reveal
molecular
basi
novel
insight
variou
lungrel
diseas
complic
howev
better
human
life
much
effort
need
valid
whether
biomark
drug
target
realli
use
earli
detect
predict
prevent
cure
lung
diseas
thu
success
product
reliabl
diagnost
kit
target
drug
could
prove
real
valu
studi
era
lung
proteom
way
